Overview
The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)
Description
The investigators are proposing a cluster randomized clinical trial to compare the effectiveness of two models of support for reproductive health clinicians to provide care for pregnant and postpartum women with an OUD: 1) a collaborative care (CC) approach based upon the Massachusetts Office-Based-Opioid Treatment (OBOT) Model that would provide onsite training, and support to providers and participants through the use of care managers (CMs) vs 2) a telesupport approach modeled on the Project Extension for Community Healthcare Outcomes (ECHO), a remote education model that provides mentorship and guided practice and participation in a learning community, via video conferencing.
Eligibility
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Females age 18 or older
- Documented pregnancy in the medical record at less than 34 weeks gestation
- Delivery date no later than December 15, 2022
- Willingness to adhere to the study schedule
- Confirmed opioid use disorder by the DSM-5 Opioid Use Disorder questionnaire
- Ability to communicate in English
- No current plan to move out of the obstetrical provider treatment area within the study timeframe of approximately 44 weeks
Exclusion Criteria:
- Experiencing cognitive or emotional impairment that precludes the participant from providing informed consent
- Current hospitalization, incarceration, or institutionalization (if women present for care after institutionalization, participation is possible
- Current court case pending that would make incarceration likely during the study treatment period (approximately 44 weeks)